non alcoholic fatty liver disease Helicobacter pylori infection
Conditions
Interventions
Sponsors
Chigasaki Municipal Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients with non alcoholic fatty liver disease 2)Patients with gastric or duodenal ulcer scar and helicobacter pylori infection
Exclusion criteria
Exclusion criteria: 1)Patients with another liver disease 2)Patients with previous hepatectomy 3)Patients with intiated or changed anitidiabetic, antidyslipidemic, antiinflammatory drugs or liver supporting therapy 4)Patients with severe infection or trauma 5)Patients with malignancy 6)Patients with gastric or duodenal ulcer in the acute phase 7)Patients druing pregnancy or lactation 8)Patients with severe liver dysfunction or renal insufficiency 9)Patients who received steroid therapy 10)Patients who were allergic to Helicobacter pylori eradication drugs 11)Patients who cann not take written informed consent 12)Patients determined to be inappropriate by phyysician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver dysfunction at pre and post Helicobacter pylori eradication | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile and insulin resistance at pre and post Helicobacter pylori eradication | — |
Countries
Japan
Contacts
Public ContactTakashi Uchiyama
Chigasaki Municipal Hospital Gastroenterology Division
Outcome results
None listed